EMA Authorised: Exforge (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Limited

View source ↗

Summary

The EMA authorised Exforge, a fixed-dose combination of valsartan and amlodipine, for hypertension; the marketing authorization holder is Novartis Europharm Lim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Novartis Europharm Limited. Decision date: 19/11/2025